Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11851653
Materials and methods for treatment of alpha-1 antitrypsin deficiency
granted -
US 11851481
Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
granted -
US 11851690
Systems and methods for the treatment of hemoglobinopathies
granted -
US 11850229
Treatment of circadian rhythm disorders
granted -
US 11844765
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11844805
Formulations of testosterone and methods of treatment therewith
granted -
US 11844801
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 11845989
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11845752
Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B
granted -
US 11840497
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted -
US 11839619
Methods for treatment of pediatric systemic mastocytosis
granted -
US 11839631
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 11840525
Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer
granted -
US 11839596
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11839604
Use of sublingual dexmedetomidine for the treatment of agitation
granted -
CN 117186084
Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus
granted -
US 11833160
Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases
granted -
US 11833211
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
granted -
US 11833210
ASH1L inhibitors and methods of treatment therewith
granted -
US 11834507
Anti-MET agonist antibody for use in the treatment of colorectal cancer
granted -
US 11833159
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted -
US 11833130
Treatment of circadian rhythm disorders
granted -
US 11826373
Methods for treatment of diseases
granted -
US 11826321
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
granted